Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0100
0.00 (0.00%)
Aug 21, 2026, 4:10 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 43.38 million as of August 21, 2026. Its market cap has decreased by -25.14% in one year.
Market Cap
43.38M
Enterprise Value
7.02M
Revenue
16.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 43.38M, a decrease of -57.20%. That is a compound annual growth rate of -16.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 43.38M | -51.05% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 77.36M |
| Amplia Therapeutics | 77.00M |
| Entropy Neurodynamics | 61.19M |
| Botanix Pharmaceuticals | 54.69M |
| Nexsen | 47.05M |
| Neurizon Therapeutics | 45.73M |
| Imugene | 40.65M |
| Argenica Therapeutics | 27.62M |